Growth suppression of human colorectal cancer cells with mutated KRAS by 3-deaza-cytarabine in 3d floating culture

Hao Luo, Kensuke Nishi, Shuhei Ishikura, Anthony Swain, Naoyuki Morishige, Ryo Yazaki, Takashi Ohshima, Senji Shirasawa, Toshiyuki Tsunoda

Research output: Contribution to journalArticle

Abstract

Background/Aim: During screening for compounds that selectively suppress growth of human colorectal cancer (CRC) spheroids with mutant (mt) KRAS, the uridine analogue, 5-bromouridine (BrUrd) was identified and its derivatives were explored. Materials and Methods: DNA incorporation in two-dimensional (2D) and three-dimensional floating (3DF) cultures was examined with the uridine analogue, 5-ethynyl-2'-deoxyuridine (EdU). The area of HKe3 CRC spheroids expressing wild type (wt) KRAS (HKe3-wtKRAS) and mtKRAS (HKe3-mtKRAS) were measured in 3DF culture with 11 BrUrd derivatives. Results: EdU was strongly incorporated into newly-synthesized DNA from HKe3-mtKRAS cells compared to HKe3-wtKRAS in 2D and 3DF culture. 3-Deaza-cytarabine, which has properties of BrUrd and cytidine, was the most effective inhibitor of HKe3-mtKRAS spheroids with the least toxicity to HKe3-wtKRAS. Growth suppression of 3-deaza-cytarabine was stronger than cytarabine in 2D culture, and toxicity was lower than gemcitabine in long-term 3DF culture. Conclusion: 3-Deaza-cytarabine exhibits properties useful for the treatment of CRC patients with mtKRAS.

Original languageEnglish
Pages (from-to)4247-4256
Number of pages10
JournalAnticancer research
Volume38
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Cytarabine
Colorectal Neoplasms
Uridine
Growth
gemcitabine
Cytidine
DNA
5-bromouridine
5-ethynyl-2'-deoxyuridine
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Growth suppression of human colorectal cancer cells with mutated KRAS by 3-deaza-cytarabine in 3d floating culture. / Luo, Hao; Nishi, Kensuke; Ishikura, Shuhei; Swain, Anthony; Morishige, Naoyuki; Yazaki, Ryo; Ohshima, Takashi; Shirasawa, Senji; Tsunoda, Toshiyuki.

In: Anticancer research, Vol. 38, No. 7, 01.07.2018, p. 4247-4256.

Research output: Contribution to journalArticle

Luo, Hao ; Nishi, Kensuke ; Ishikura, Shuhei ; Swain, Anthony ; Morishige, Naoyuki ; Yazaki, Ryo ; Ohshima, Takashi ; Shirasawa, Senji ; Tsunoda, Toshiyuki. / Growth suppression of human colorectal cancer cells with mutated KRAS by 3-deaza-cytarabine in 3d floating culture. In: Anticancer research. 2018 ; Vol. 38, No. 7. pp. 4247-4256.
@article{8d5320eacffa4741842e2b1a9e9c700f,
title = "Growth suppression of human colorectal cancer cells with mutated KRAS by 3-deaza-cytarabine in 3d floating culture",
abstract = "Background/Aim: During screening for compounds that selectively suppress growth of human colorectal cancer (CRC) spheroids with mutant (mt) KRAS, the uridine analogue, 5-bromouridine (BrUrd) was identified and its derivatives were explored. Materials and Methods: DNA incorporation in two-dimensional (2D) and three-dimensional floating (3DF) cultures was examined with the uridine analogue, 5-ethynyl-2'-deoxyuridine (EdU). The area of HKe3 CRC spheroids expressing wild type (wt) KRAS (HKe3-wtKRAS) and mtKRAS (HKe3-mtKRAS) were measured in 3DF culture with 11 BrUrd derivatives. Results: EdU was strongly incorporated into newly-synthesized DNA from HKe3-mtKRAS cells compared to HKe3-wtKRAS in 2D and 3DF culture. 3-Deaza-cytarabine, which has properties of BrUrd and cytidine, was the most effective inhibitor of HKe3-mtKRAS spheroids with the least toxicity to HKe3-wtKRAS. Growth suppression of 3-deaza-cytarabine was stronger than cytarabine in 2D culture, and toxicity was lower than gemcitabine in long-term 3DF culture. Conclusion: 3-Deaza-cytarabine exhibits properties useful for the treatment of CRC patients with mtKRAS.",
author = "Hao Luo and Kensuke Nishi and Shuhei Ishikura and Anthony Swain and Naoyuki Morishige and Ryo Yazaki and Takashi Ohshima and Senji Shirasawa and Toshiyuki Tsunoda",
year = "2018",
month = "7",
day = "1",
doi = "10.21873/anticanres.12721",
language = "English",
volume = "38",
pages = "4247--4256",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Growth suppression of human colorectal cancer cells with mutated KRAS by 3-deaza-cytarabine in 3d floating culture

AU - Luo, Hao

AU - Nishi, Kensuke

AU - Ishikura, Shuhei

AU - Swain, Anthony

AU - Morishige, Naoyuki

AU - Yazaki, Ryo

AU - Ohshima, Takashi

AU - Shirasawa, Senji

AU - Tsunoda, Toshiyuki

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background/Aim: During screening for compounds that selectively suppress growth of human colorectal cancer (CRC) spheroids with mutant (mt) KRAS, the uridine analogue, 5-bromouridine (BrUrd) was identified and its derivatives were explored. Materials and Methods: DNA incorporation in two-dimensional (2D) and three-dimensional floating (3DF) cultures was examined with the uridine analogue, 5-ethynyl-2'-deoxyuridine (EdU). The area of HKe3 CRC spheroids expressing wild type (wt) KRAS (HKe3-wtKRAS) and mtKRAS (HKe3-mtKRAS) were measured in 3DF culture with 11 BrUrd derivatives. Results: EdU was strongly incorporated into newly-synthesized DNA from HKe3-mtKRAS cells compared to HKe3-wtKRAS in 2D and 3DF culture. 3-Deaza-cytarabine, which has properties of BrUrd and cytidine, was the most effective inhibitor of HKe3-mtKRAS spheroids with the least toxicity to HKe3-wtKRAS. Growth suppression of 3-deaza-cytarabine was stronger than cytarabine in 2D culture, and toxicity was lower than gemcitabine in long-term 3DF culture. Conclusion: 3-Deaza-cytarabine exhibits properties useful for the treatment of CRC patients with mtKRAS.

AB - Background/Aim: During screening for compounds that selectively suppress growth of human colorectal cancer (CRC) spheroids with mutant (mt) KRAS, the uridine analogue, 5-bromouridine (BrUrd) was identified and its derivatives were explored. Materials and Methods: DNA incorporation in two-dimensional (2D) and three-dimensional floating (3DF) cultures was examined with the uridine analogue, 5-ethynyl-2'-deoxyuridine (EdU). The area of HKe3 CRC spheroids expressing wild type (wt) KRAS (HKe3-wtKRAS) and mtKRAS (HKe3-mtKRAS) were measured in 3DF culture with 11 BrUrd derivatives. Results: EdU was strongly incorporated into newly-synthesized DNA from HKe3-mtKRAS cells compared to HKe3-wtKRAS in 2D and 3DF culture. 3-Deaza-cytarabine, which has properties of BrUrd and cytidine, was the most effective inhibitor of HKe3-mtKRAS spheroids with the least toxicity to HKe3-wtKRAS. Growth suppression of 3-deaza-cytarabine was stronger than cytarabine in 2D culture, and toxicity was lower than gemcitabine in long-term 3DF culture. Conclusion: 3-Deaza-cytarabine exhibits properties useful for the treatment of CRC patients with mtKRAS.

UR - http://www.scopus.com/inward/record.url?scp=85049805180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049805180&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12721

DO - 10.21873/anticanres.12721

M3 - Article

C2 - 29970558

AN - SCOPUS:85049805180

VL - 38

SP - 4247

EP - 4256

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -